MYOK
MyoKardia

1,263
Loading...
Loading...
MyoKardia is a clinical-stage biopharmaceutical company that engages in discovering, developing, and commercializing targeted therapies for the treatment of rare cardiovascular diseases. The company's focus is on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It utilizes its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy and dilated cardiomyopathy. The company was founded in 2012 and is headquartered in Brisbane, California.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of MyoKardia Inc?
What is the 52-week high for MyoKardia Inc?
What is the 52-week low for MyoKardia Inc?
What was MyoKardia Inc stock price yesterday?
What is the PE ratio of MyoKardia Inc?
What is the Price-to-Book ratio of MyoKardia Inc?
What is the 50-day moving average of MyoKardia Inc?

Latest MYOK News

View
No MYOK news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.